Cytomegalovirus microRNAs Facilitate Persistent Virus Infection in Salivary Glands
Micro (mi)RNAs are small non-coding RNAs that regulate the expression of their targets' messenger RNAs through both translational inhibition and regulation of target RNA stability. Recently, a number of viruses, particularly of the herpesvirus family, have been shown to express their own miRNAs to control both viral and cellular transcripts. Although some targets of viral miRNAs are known, their function in a physiologically relevant infection remains to be elucidated. As such, no in vivo phenotype of a viral miRNA knock-out mutant has been described so far. Here, we report on the first functional phenotype of a miRNA knock-out virus in vivo. During subacute infection of a mutant mouse cytomegalovirus lacking two viral miRNAs, virus production is selectively reduced in salivary glands, an organ essential for virus persistence and horizontal transmission. This phenotype depends on several parameters including viral load and mouse genetic background, and is abolished by combined but not single depletion of natural killer (NK) and CD4+ T cells. Together, our results point towards a miRNA-based immunoevasion mechanism important for long-term virus persistence.
Vyšlo v časopise:
Cytomegalovirus microRNAs Facilitate Persistent Virus Infection in Salivary Glands. PLoS Pathog 6(10): e32767. doi:10.1371/journal.ppat.1001150
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001150
Souhrn
Micro (mi)RNAs are small non-coding RNAs that regulate the expression of their targets' messenger RNAs through both translational inhibition and regulation of target RNA stability. Recently, a number of viruses, particularly of the herpesvirus family, have been shown to express their own miRNAs to control both viral and cellular transcripts. Although some targets of viral miRNAs are known, their function in a physiologically relevant infection remains to be elucidated. As such, no in vivo phenotype of a viral miRNA knock-out mutant has been described so far. Here, we report on the first functional phenotype of a miRNA knock-out virus in vivo. During subacute infection of a mutant mouse cytomegalovirus lacking two viral miRNAs, virus production is selectively reduced in salivary glands, an organ essential for virus persistence and horizontal transmission. This phenotype depends on several parameters including viral load and mouse genetic background, and is abolished by combined but not single depletion of natural killer (NK) and CD4+ T cells. Together, our results point towards a miRNA-based immunoevasion mechanism important for long-term virus persistence.
Zdroje
1. MocarskiES
ShenkT
PassRF
2007 Cytomegaloviruses.
KnipeDM
HowleyPM
GriffinDE
LambRA
MartinMA
Fields Virology. 5th ed Philadelphia Lippincott, Williams & Wilkins 2701 2772
2. ScalzoAA
CorbettAJ
RawlinsonWD
ScottGM
Degli-EspostiMA
2007 The interplay between host and viral factors in shaping the outcome of cytomegalovirus infection. Immunol Cell Biol 85 46 54
3. GottweinE
CullenBR
2008 Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe 3 375 387
4. AmbrosV
2004 The functions of animal microRNAs. Nature 431 350 355
5. BaekD
VillenJ
ShinC
CamargoFD
GygiSP
2008 The impact of microRNAs on protein output. Nature 455 64 71
6. SelbachM
SchwanhausserB
ThierfelderN
FangZ
KhaninR
2008 Widespread changes in protein synthesis induced by microRNAs. Nature 455 58 63
7. SullivanCS
SungCK
PackCD
GrundhoffA
LukacherAE
2009 Murine Polyomavirus encodes a microRNA that cleaves early RNA transcripts but is not essential for experimental infection. Virology 387 157 167
8. PolicB
HengelH
KrmpoticA
TrgovcichJ
PavicI
1998 Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med 188 1047 1054
9. PolicB
JonjicS
PavicI
CrnkovicI
ZoricaI
1996 Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo. J Gen Virol 77 Pt 2 217 225
10. BuckAH
Santoyo-LopezJ
RobertsonKA
KumarDS
ReczkoM
2007 Discrete clusters of virus-encoded microRNAs are associated with complementary strands of the genome and the 7.2-kilobase stable intron in murine cytomegalovirus. J Virol 81 13761 13770
11. DolkenL
PerotJ
CognatV
AliouaA
JohnM
2007 Mouse cytomegalovirus microRNAs dominate the cellular small RNA profile during lytic infection and show features of posttranscriptional regulation. J Virol 81 13771 13782
12. DunnW
TrangP
ZhongQ
YangE
van BelleC
2005 Human cytomegalovirus expresses novel microRNAs during productive viral infection. Cell Microbiol 7 1684 1695
13. GreyF
AntoniewiczA
AllenE
SaugstadJ
McSheaA
2005 Identification and characterization of human cytomegalovirus-encoded microRNAs. J Virol 79 12095 12099
14. WarmingS
CostantinoN
CourtDL
JenkinsNA
CopelandNG
2005 Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res 33 e36
15. AraseH
MocarskiES
CampbellAE
HillAB
LanierLL
2002 Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296 1323 1326
16. SmithHR
HeuselJW
MehtaIK
KimS
DornerBG
2002 Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A 99 8826 8831
17. SacherT
PodlechJ
MohrCA
JordanS
RuzsicsZ
2008 The major virus-producing cell type during murine cytomegalovirus infection, the hepatocyte, is not the source of virus dissemination in the host. Cell Host Microbe 3 263 272
18. CampbellAE
CavanaughVJ
SlaterJS
2008 The salivary glands as a privileged site of cytomegalovirus immune evasion and persistence. Med Microbiol Immunol 197 205 213
19. HuangS
HendriksW
AlthageA
HemmiS
BluethmannH
1993 Immune response in mice that lack the interferon-gamma receptor. Science 259 1742 1745
20. LussierG
BerthiaumeL
PaymentP
1974 Electron microscopy of murine cytomegalovirus: development of the virus in vivo and in vitro. Arch Gesamte Virusforsch 46 269 280
21. JonjicS
MutterW
WeilandF
ReddehaseMJ
KoszinowskiUH
1989 Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes. J Exp Med 169 1199 1212
22. OsbornJE
WalkerDL
1971 Virulence and Attenuation of Murine Cytomegalovirus. Infect Immun 3 228 236
23. ReddehaseMJ
WeilandF
MunchK
JonjicS
LuskeA
1985 Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J Virol 55 264 273
24. SmithMG
1954 Propagation of salivary gland virus of the mouse in tissue cultures. Proc Soc Exp Biol Med 86 435 440
25. Stern-GinossarN
ElefantN
ZimmermannA
WolfDG
SalehN
2007 Host immune system gene targeting by a viral miRNA. Science 317 376 381
26. MatloubianM
DavidA
EngelS
RyanJE
CysterJG
2000 A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 1 298 304
27. GeissmannF
CameronTO
SidobreS
ManlongatN
KronenbergM
2005 Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol 3 e113
28. AbelS
HundhausenC
MentleinR
SchulteA
BerkhoutTA
2004 The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J Immunol 172 6362 6372
29. DayC
PatelR
GuillenC
WardlawAJ
2009 The chemokine CXCL16 is highly and constitutively expressed by human bronchial epithelial cells. Exp Lung Res 35 272 283
30. GreyF
MeyersH
WhiteEA
SpectorDH
NelsonJ
2007 A human cytomegalovirus-encoded microRNA regulates expression of multiple viral genes involved in replication. PLoS Pathog 3 e163
31. Stern-GinossarN
SalehN
GoldbergMD
PrichardM
WolfDG
2009 Analysis of human cytomegalovirus-encoded microRNA activity during infection. J Virol 83 10684 10693
32. PfefferS
SewerA
Lagos-QuintanaM
SheridanR
SanderC
2005 Identification of microRNAs of the herpesvirus family. Nat Methods 2 269 276
33. BruneW
HengelH
KoszinowskiUH
2001 A mouse model for cytomegalovirus infection. Curr Protoc Immunol Chapter 19 Unit 19 17
34. CobboldSP
JayasuriyaA
NashA
ProsperoTD
WaldmannH
1984 Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312 548 551
35. KooGC
PeppardJR
1984 Establishment of monoclonal anti-Nk-1.1 antibody. Hybridoma 3 301 303
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 10
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Retroviral RNA Dimerization and Packaging: The What, How, When, Where, and Why
- Viral Replication Rate Regulates Clinical Outcome and CD8 T Cell Responses during Highly Pathogenic H5N1 Influenza Virus Infection in Mice
- Antimicrobial Peptides: Primeval Molecules or Future Drugs?
- Crystal Structure of DotD: Insights into the Relationship between Type IVB and Type II/III Secretion Systems